Clinical Trial Update: Efficacy of ActiveMatrix on Spinal SSI Rate [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of ActiveMatrix on reducing surgical site infection rates in lumbar spinal stenosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Back Pain Lower Back
• Spinal Stenosis
• Surgical Site Infection

Drugs mentioned

• ActiveMatrix (Connective Tissue Allograft)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Spinal Stenosis Lumbar, Surgical Site Infection | Phase 4 | Status: NOT_YET_RECRUITING